what is known already: Individuals with suboptimal intrauterine development are at greater risk of metabolic diseases such as type II diabetes, obesity and cardiovascular disease. study design, size, duration: Umbilical cords (n ¼ 283) from the GUSTO (growing up in Singapore towards healthy outcomes) birth cohort study, and primary MSC isolates established from SGA and matched control cases (n ¼ 6 per group), were subjected to gene expression analysis and candidate genes were studied for functional validation.
Introduction
It is well established that suboptimal intrauterine experiences influence the risk of developing type 2 diabetes mellitus, cardiovascular disease and obesity in later life: a phenomenon sometimes called developmental programming and encapsulated within the developmental origins of health and disease (DOHaD) paradigm Tarry-Adkins and Ozanne, 2011) . Earlier studies have focused on birthweight (BW)-disease risk relationships (Barker, 1994 (Barker, , 1997 , and more recently it has become clear that developmental programming can be independent of fetal growth impairment (Roseboom et al., 2000; Godfrey et al., 2011) . Current concepts of DOHaD suggest that fetal growth restriction is an immediate response of the fetus to limiting conditions particularly in the supply of nutrients and oxygen, whereas the longer term response is an epigenetically mediated developmentally plastic response to more subtle intrauterine cues Low et al., 2011) . In the absence of good biomarkers for developmental induction of programming, the study of the growth-restricted infants remains the dominant approach to study developmental programming in humans. This study was designed to explore whether stem cells taken from the umbilical cord may be a useful tissue to overcome the obvious constraints and in particular to indicate a direction for research into the mechanism of the development of insulin resistance which, although primed before birth, does not develop until later after birth (Mericq et al., 2005) .
Small for gestational age (SGA) neonates are very insulin sensitive and indeed can have much higher glucose requirements than normal sized infants (Gentz et al., 1969) . But limited data suggest that it is only at the age of expected weaning that insulin resistance develops Mericq et al., 2005) . It may be that this early insulin sensitivity assists in promoting adiposity once the child is born and fed on high fat milk (Kuzawa, 1998) , suggesting the critical role of fat reserves in buffering the energetically demanding brain at weaning (Leonard et al., 2003) . But by the age of seven, SGA children have pronounced insulin resistance (Hofman et al., 1997) . Nothing is known of the mechanisms underpinning this switch in insulin sensitivity. Lucas and Singhal (Singhal et al., 2003) and others (Morrison et al., 2010) have suggested the critical role of infant catch up growth although this is not supported by studies in the Helsinki cohort (Forsén et al., 2000; Barker et al., 2005) . Whether the catch up growth is a cause of the insulin sensitivity switch or not, it is well established in rodents that prenatal experience sensitizes the offspring to become more obese on a high fat post-natal diet (Howie et al., 2009) . Hyperinsulinemia might also play a role in driving post-natal infant somatic growth since fasting insulin levels are significantly higher in SGA infants who have had a rapid catch up growth in weight (Soto et al., 2003) .
We isolated Wharton's Jelly-derived mesenchymal stem cells (MSCs) from fresh umbilical cords of normal and growth-restricted infants, as they are an abundant cell species and can be harvested with no significant ethical issues beyond consent (Bongso and Fong, 2013) . MSCs are multipotent and can be differentiated in vitro into various lineages (reviewed in Batsali et al., 2013) . We compared global transcriptome changes in MSCs from SGA and control infants prior to and following insulin stimulation. We found the expression level patterns of the immediate early gene EGR-1 and the pro-inflammatory gene COX-2 to be significantly altered in cells derived from SGA subjects. In addition to these altered patterns of gene expression, MSCs from SGA individuals show significant differences in glucose uptake and proliferation suggesting that they maintain the cellular memory of growth restriction/programming. We confirmed these expression changes in mRNA extracted from frozen umbilical cord samples from a birth cohort. We suggest that MSCs are a useful system for studies of the molecular mechanisms underlying the developmental trajectory towards metabolic diseases.
Materials and Methods

Clinical populations and sample collection
All umbilical cord specimens were derived from babies born at the National University Hospital (NUH), in Singapore. Written parental consent to participate in the study was given. Ethical approval was granted by the ethics board of NUH, which is the Domain Specific Review Board (DSRB). The data shown in Fig. 7 were generated from frozen umbilical cord specimens collected from the growing up in Singapore towards healthy outcomes (GUSTO) birth cohort study (Soh et al., 2013) .
Assessment of fetal growth characteristics
For the isolation of fresh MSCs from SGA and corresponding normal control neonates, subjects were randomly chosen from the obstetric ward at NUH based on their fetal growth determined by ultrasonography. Ultrasound measurements were derived from Hadlock formulas (Hadlock et al., 1982 (Hadlock et al., , 1984 and scans were conducted in a standard manner, using ultrasound machines (Aloka SSD-4000, GE Voluson E8). Fetal growth characteristics (biparietal diameter, femur and humerus lengths, head and abdominal circumferences) were measured at 19-21, 26-28 and 32-34 (scan 4) weeks of gestation. All fetal growth characteristics for each subject were converted to standard deviation scores (SDS) using internally derived gestational age-specific means and standard deviations. SGA was diagnosed by ultrasonography as growth between the 5th and 10th percentile compared with a normal reference population.
Preparation and propagation of mesenchymal stem cells from human umbilical cord
Mesenchymal stem cells (MSCs) were prepared following published procedures (Fong et al., 2010) . Primary cell isolates were passaged up to 10 times and the same passage numbers were used for the experiments shown. Wharton's jelly-derived MSCs employed in the study isolated from SGA infants , and control subjects were ethnicity and gender matched. The prevalence of SGA with diagnosed fetal growth restriction was rather low at around 8% of all cords collected in our study. In addition, not all MSC isolates from all incoming specimens could be propagated successfully. All isolates were derived from female neonates with gestational ages between 37 and 39 weeks.
Flow cytometry based characterization of MSC isolates from Wharton's jelly Stemness features of Wharton Jelly-derived MSCs were determined by analysis of specific cell surface markers using flow cytometry. MSCs from monolayer cultures were trypsinized and washed twice with ice-cold PBS. After resuspending the cells in 1 ml PBS, formaldehyde was added to a final concentration of 4%. The cells were fixed for 10 min at room temperature and chilled on ice for 1 min. The cells were then incubated for 1 h at room temperature with conjugated primary antibodies (PE-CD29, APC-CD44, eBioscience, San Diego, CA, USA). The cells were resuspended in 0.5 ml PBS and analysed using a BD FACS Canto flow cytometer (Becton Dickinson).
Cell proliferation
Cell proliferation was measured using the AlamarBlue w Cell Viability Reagent (Invitrogen) according to manufacturer's instructions. Briefly, cells were plated to allow them to adhere and grow for 24 h at 378C and 5% CO 2 . Then 1/10th volume AlamarBlue w reagent was added directly to cells in culture medium and incubated for 2 h at 378C before fluorescence measurement is made. A fluorescence excitation wavelength of 540 -570 nm was used and fluorescence emission at 580 -610 nm was read. The average fluorescence values of the cell culture medium alone (background) was subtracted from the fluorescence values of experimental wells.
EGR-1/COX-2 over-expression and knockdown studies For over-expression studies, human MSCs were transfected using Lipofectamine LTX (Invitrogen) with 2.5 mg GFP-tagged plasmid containing the human EGR-1 gene (RG209956; Origene Technologies) or COX-2 gene (SC323764; Origene Technologies). For knockdown studies, siRNA against hEGR-1 (ON-TARGETplus SMARTpool-Human EGR1; Cat. No. L-006526-00-0005) was obtained from Thermo Scientific. Smartpool siRNA of the following sequences was used: 
RNA extraction
Umbilical cord tissue (300 mg) was first placed in a sterile Dispomix tube (Medic Tools, AG, Zug, Switzerland) and homogenized in Trizol. The samples were processed according to standard procedures using phenol/ chloroform extractions and ethanol precipitations. The isolated RNA was purified using the RNeasy Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. RNA concentration was measured using a nanodrop ND-8000 spectrophotometer (Nanodrop Technologies, Wilmington, DE, USA), and RNA integrity was determined using the Agilent 2100 Bioanalyzer and RNA 6000 Nano Labchips (Agilent Technologies, Santa Clara, CA, USA). RNA samples from frozen umbilical cord acceptable for downstream applications had RNA Integrity Numbers (RIN) ≥8. RNA extraction from MSCs followed the same procedures as described above excluding the use of Dispomix tubes and RNA purified from MSC isolates usually had RIN values around 10.
Gene expression microarray
HumanHT-12 v4 Expression BeadChips (cat#BD-103-0204, Illumina) were used for gene expression analysis following the manufacturer's instructions. The data were extracted by the Illumina GenomeBeadStudioTM software for further analysis. Background subtraction was performed, data were exported and probes were filtered for the determination of the P-values ,0.05 and NBEADS .3 using R. Data were then loaded into Arraystudio (Omicsoft) and normalized using quantile normalization. All samples with MAD scores less than 25 were removed from the analysis. Data were subjected to principal component analysis and unsupervised hierarchical clustering. To identify probes significantly differentially expressed, one-way ANOVAs (multiple testing correction: Benjamini & Hochberg) were performed. Processed and raw data were deposited in GEO (GSE52845).
Pathway analysis
All genes that were significantly differentially expressed between SGA and control groups were subjected to pathway enrichment and de novo network analysis. Pathway analysis was performed in GeneGo (MetaCore TM ).
Quantitative real-time PCR
For qRT -PCR, total RNA (4 mg) was reverse transcribed using a High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Inc., ABI, CA, USA). Target genes and two endogenous control housekeeping genes (beta-actin and GAPDH) were analysed. The threshold cycles (Ct) of samples provided by the equipment software (SDS 2.4) were normalized by the average Ct of controls using △Ct,Target¼Ct,Target-Ct,AvgControl. In order to quantify relative gene expression levels, we used the 2 2DDCt method (Livak and Schmittgen, 2001 ) and the data were plotted as fold change (Figs 1C, 2B, 4C and 6) . For the results shown in Fig. 7 , linear regression analysis was applied on the delta Ct values of target genes against a variety of clinical measures.
In vitro glucose uptake assay
We treated the cells with 100 nM insulin and transfected EGR-1, COX-2 or GFP at various time points (0, 24 h, 48 h). At each time point, we collected 50 ml of the medium and determined the concentration of glucose by using the QuantiChrom Glucose Assay kit (Medibena Bioassay systems) following the manufactures instructions. In brief, glucose was directly measured in the medium supernatants using a proprietary o-toluidine method utilizing a specific colourimetric reaction with glucose. Absorbance measured at 630 nm is directly proportional to the glucose concentration in the medium as validated via a standard curve against fixed glucose concentrations. The data were normalized against the total protein content for each individual sample. Cells were collected via trypsinization and lysed with standard RIPA buffer. The protein concentration was measured using the Bio-Rad protein assay kit. For Supplementary data, Fig. S3 , data were normalized against the total genomic DNA. Genomic DNA was extracted using the DNeasy Blood and Tissue Kit (QIAGEN, Venlo, Netherlands) following the manufacturer's protocol. The concentration of the eluted DNA was determined using the nanodrop ND-8000 spectrophotometer (Nanodrop Technologies).
Western blotting
MSCs were washed twice with PBS and grown in alpha-MEM (GIBCO) without serum for 18 -20 h. After serum starvation, cells were treated with insulin (100 nM) for various time points. Cell lysates were prepared EGR-1 pathways in MSCs from SGA babies following standard protocols, frozen on dry ice and kept at 2808C for further usage. Total protein lysates (30 mg) were loaded on SDS -PAGE, and proteins were transferred to polyvinyl difluoride (PVDF) membranes. Primary antibodies used were anti-pAKT (S470), anti-AKT (Santa Cruz, CA, USA), anti-EGR1 (Cell Signaling, MA, USA) and anti-b-Actin (Abcam, Cambridge, MA, USA). Secondary antibodies used were either IRDye 680LT or 800CW from LI-COR Biosciences. Bands were quantified by densitometric measurements using the LI-COR odyssey software. The band densities were normalized to the density of b-actin. The data shown in Fig. 3B (right panel) represent mean + SD from three different blots.
ELISA
For the measurement of PGE2 release upon insulin stimulation of MSC isolates (Fig. 4D) , 0.5 ml of the supernatant (cell growth medium) were collected from each time point and the concentration of PGE2 was measured using a high sensitivity ELISA kit from Abcam (cat# ab133055) following the manufacturer's instructions.
Statistics
Differences in cell proliferation between the SGA and control groups across the 5-day time period were analysed using repeated measures analysis of variance (ANOVA), testing for potential interactions between time and 'SGA versus control' on the outcome of cell proliferation. In the case of a statistically significant interaction, differences in cell proliferation between the SGA and control groups were tested at each time point. The effects of acute insulin treatment and EGR-1/COX-2 over-expression on cell proliferation as well as glucose uptake were analysed using two-way ANOVA. For comparisons between groups in experiments describing fold gene expression and ELISA, paired t-tests were conducted. Significant differences were expressed as '*' for P-values ,0.05 and '**' for P-values ,0.01. Statistical analysis was performed using SPSS version 16.0 (IBM, SPSS Statistics, Armonk, NY, USA).
Results
MSCs derived from SGA neonates show higher cell proliferation rates and express low basal levels of EGR-1
After obtaining consent from the local Domain Specific Review Board, we established a collection of primary Wharton's jelly-derived MSC were treated with 100 nM insulin for 1 h and quantification of PGE2 release into the cell medium was carried out by ELISA (error bars represent SD (n ¼ 3, **P , 0.01, two-way ANOVA)).
EGR-1 pathways in MSCs from SGA babies isolates obtained from neonates born SGA and normal control subjects. Growth restriction was diagnosed using ultrasonography as described in Materials and Methods. The prevalence of SGA was found to be low, in 8% of all subjects enrolled in this study. All study subjects available for our study were full term between 37 and 39 weeks of gestation. We further matched the SGA-derived cells according to gender and ethnicity. As cord tissue harbours a variety of cell types, we employed published protocols for the enriched extraction of MSCs (Fong et al., 2010) and prior to using the cells for research projects, they were characterized via flow cytometry to detect specific surface antigens such as CD29 and CD44 (see Materials and Methods), which are both expressed by MSCs from Wharton's jelly (Wang et al., 2004) . We did not find any difference in the expression of the MSC markers between isolates from SGA and normal control subjects (Supplementary data, Fig. S1 ). In addition, expression of known MSC-associated markers such as CD9, IL6ST and IL1B was detected for all MSC groups in early to late passages, whereas genes specific for pluripotent embryonic stem cells such as NANOG, SOX2 and POU5F1 were not expressed or expressed at a very low level in multipotent Wharton's jelly-derived MSCs (Supplementary data, Fig. S2 ). This finding is in line with published observations (Fong et al., 2011) . We did not observe any differences in cellular senescence in all our MSC isolates, as no expression of beta-galactosidase was detectable (data not shown). Overall, we concluded that the majority of our cell isolate was mesenchymal in nature and in a proliferative state.
During routine culturing of primary MSC isolates, we observed faster doubling times for MSCs from the growth-restricted individuals. In order to quantify this finding, we carried out a set of experiments to measure the proliferative rates of cell isolates from the two groups by comparing MSCs from each group in basic cell proliferation assays. Before individual MSC isolates were compared, we established the optimal cell densities for a 5-day proliferation assay in order to ensure linear growth for all MSCs tested (see Materials and Methods). As shown in Fig. 1A , the SGA group of MSC isolates (MSC-01, -23, -56, -70 and -75) grew significantly faster over the course of 5 days compared with the controls Figure 4 Continued. MSC-44, -50, -57 and -60. The differences between the groups were significant as shown by a two-way ANOVA (three biological sample repeats, P , 0.01). In order to identify the molecular drivers accounting for these differences in cell proliferation, we studied global transcriptomic changes between the groups by conducting gene expression microarray experiments comparing MSCs from four SGA individuals with MSCs from four controls. We identified 83 differentially expressed probes between the two groups with P-value ,0.05 and |FC| .1.5, (see heat map shown in Fig. 1B) . Analysis of the data revealed an enrichment of pathways regulating cell proliferation, cytokine-mediated signalling and prostaglandin E2 function (Table I) . One of the most significant genes identified in the analysis was the transcription factor EGR-1, previously known to regulate cell proliferation in cancer cells ; it was found to be down-regulated in our MSC isolates from SGA babies and this was confirmed by RT-PCR comparing all MSC isolates from the two groups (Fig. 1C) .
EGR-1 is a key regulator of MSC proliferation
To assess the putative regulatory role for EGR-1 in the growth of MSCs, we transfected an expression vector for EGR-1, or GFP which served as negative control, into both a representative SGA (MSC-01), and a representative control, MSC line (MSC-44). EGR-1 inhibited cell proliferation in both MSC isolates, albeit to a greater extent in the SGA-derived line MSC-01 ( Fig. 2A ; n ¼ 3, P , 0.01, two-way ANOVA). The reverse approach was taken by employing EGR-1-specific siRNAs compared with scrambled control siRNAs (Fig. 2B) demonstrating that knockdown of EGR-1 led to a significant increase in proliferation of MSC-44 control cells to the level seen for the SGA cell line (n ¼ 3, P , 0.01, two-way ANOVA).
Wharton's jelly-derived MSCs from SGA neonates exert enhanced insulin sensitivity
When stimulated with insulin, MSCs derived from the SGA group (examples MSC isolates #23 and #75) consumed significantly more glucose from the culture medium over time when compared with their ethnicitymatched controls (#44 and #60, Fig. 3A ; P , 0.01, two-way ANOVA). Although we normalized the raw glucose uptake data against the total amount of protein for every sample, to further ensure that the results of the glucose uptake assay were not confounded by differences in cell proliferation rates between the MSC isolates, we also normalized the glucose uptake data against the total amount of DNA. The results were found to be similar (see Supplementary data, Fig. S3 ). In parallel, we found that the SGA-derived MSCs have higher levels of pAKT from 10 to 30 min after exposure to the insulin trigger than their ethnicitymatched controls (Fig. 3B) . However, when exposed to insulin treatment, the SGA MSC isolate exerted slower proliferation rates compared with the controls, for which insulin had no effect ( Fig. 3C ; P , 0.01, two-way ANOVA).
COX-2 and EGR-1 are strongly up-regulated in SGA-derived MSC isolates after insulin stimulation
We next investigated transcriptomic changes in the MSC isolates after exposure to insulin. For this purpose, we conducted a series of gene expression microarray experiments with a selected SGA (MSC-23) and normal control MSC preparation (MSC-44) after treatment with insulin at different time points. Interestingly, amongst others, one of the most significantly changed genes, amongst others, was again EGR-1, which, under these conditions, showed a strong up-regulation in the SGA group of MSCs in response to shorter insulin stimulation (Fig. 4A) . After longer insulin treatment, various genes were differentially expressed. We were particularly interested in the gene encoding prostaglandin-endoperoxide synthase 2, also known as cyclooxygenase 2 (PTGS-2, COX-2, Fig. 4B ). COX-2 and the modulation of its activity have been related to important metabolic functions (Fain et al., 2001) . We confirmed the general trend of an insulindependent and SGA-specific increase in COX-2 and EGR-1 expression by comparing all SGA and control MSC isolates available, in addition to those used in the original microarray studies (Fig. 4C) . COX-2 is a known pro-inflammatory gene, which encodes the key enzyme for the biosynthesis of certain prostaglandins such as PGE2. As shown in Fig. 4D , PGE2 is secreted at higher concentrations into the medium from representative SGA-derived MSCs, which is in accordance with the observed enhanced COX-2 levels in these cells following the insulin challenge.
EGR-1 and COX-2 over-expression increase glucose uptake in SGA-derived MSCs
Insulin signalling has been shown to positively regulate COX-2 expression (Cao et al., 2007) , as well as EGR-1 induction in a PI3K-dependent manner (Keeton et al., 2003) . Both EGR-1 and COX-2 over-expression significantly increased glucose uptake indicating a change in cellular metabolism. The increase in glucose uptake was found to be accelerated in the SGA-derived MSC isolates between 24 and 48 h (Fig. 5, upper  panel) , but not in the control MSCs (Fig. 5, lower panel) .
EGR-1 up-regulates COX-2 levels and induces EGR-1 target genes involved in the regulation of cell proliferation, oxidative stress and glucose uptake COX-2 expression may be regulated, either directly or indirectly, through the action of EGR-1. In order to test this hypothesis, we conducted .. ................................................................................. .....
Table I
Pathway analyses of gene expression microarray data comparison between SGA and normal MSC isolates (described in Fig. 1 ) revealed enriched pathways for regulation of cell proliferation and prostaglandin E2 (PGE2) function.
Pathway
P-value
Positive regulation of leukocyte proliferation 3.881E-05
Positive regulation of mast cell proliferation 6.641E-05
Regulation of mast cell proliferation 6.641E-05
Cytokine-mediated signalling pathway 1.488E-04
Negative regulation of cell proliferation 1.628E-04
Response to cytokine stimulus 1.776E-04
Regulation of lymphocyte proliferation 2.520E-04
Regulation of mononuclear cell proliferation 2.590E-04
Regulation of leukocyte proliferation 3.043E-04 PGE2 pathways in cancer 7.780E-04
EGR-1 pathways in MSCs from SGA babies RT-PCR studies measuring COX-2 expression in MSCs transfected with EGR-1 and a control GFP expression vector. As shown in Fig. 6A , we detected a strong up-regulation of COX-2 expression when EGR-1 was ectopically expressed in two SGA-derived MSC isolates (MSC-01 and -23). In addition, we selected known EGR-1 regulated genes from our previous gene expression microarray data set, which have been described to regulate cell proliferation. Over-expression of EGR-1 significantly increased the levels of most of these known target genes (Fig. 6A) . After establishing that COX-2 is an EGR-1 regulated gene in our MSC model, we tested whether COX-2 over-expression would affect the expression of the above candidate genes. Two of the genes, superoxide dismutase 2 (SOD2) and tribbles pseudokinase 1 (TRIB1), found to be strongly up-regulated by EGR-1, were also COX-2 dependent (Fig. 6B ). In contrast, COX-2 over-expression did not directly influence EGR-1 expression. The EGR-1 and COX-2 mediated up-regulation of SOD2 and TRIB1 was more pronounced in MSCs derived from SGA neonates, as the two representative control cell isolates MSC-44 and MSC-57 did not exert an up-regulation of the two genes to the same extent as in SGAderived MSCs following EGR-1 and COX-2 transfections (Fig. 6C) . We also monitored the expression levels of two mammalian glucose transporters, GLUT1 and GLUT4, prior and post over-expression of EGR-1 and COX-2. As shown in Fig. 6D , GLUT1 levels were found up-regulated in two representative SGA and in two control MSC isolates after overexpressing the two target genes (left panel). However, the GLUT1 expression levels in response to COX-2 over-expression varied between the MSC isolates tested, but were significantly up-regulated for both the SGA and control groups. In contrast, the levels of GLUT4 were found to be higher in response to EGR-1 in the two SGA isolates studied (right panel) indicating differences in EGR-1-dependent glucose transporter induction and utilization in growth-restricted neonates.
EGR-1 and COX-2 expression levels are highly associated with each other and with fetal growth in frozen umbilical cord tissue
We accessed frozen archived umbilical cords from the Singapore GUSTO birth cohort study (Soh et al., 2013) . GUSTO is a longitudinal cohort aiming to track participants during various stages of their preand post-natal life and to particularly shed light on the roles for environmental and developmental factors shaping the risk for metabolic disease later in life. Specimens taken from the umbilical cord were snap-frozen in liquid nitrogen and stored long-term at 2808C. We ascertained whether expression levels of EGR-1 are associated with growth characteristics and birth outcomes of the neonates. First, we conducted RT -PCR experiments using cord specimens from 284 individuals. Figure 7A shows that COX-2 and EGR-1 expression levels are highly correlated EGR-1 pathways in MSCs from SGA babies (R ¼ 0.65, P , 0.001, N ¼ 283) indicating a potential functional relationship and supporting our findings in MSCs. Amongst all other EGR-1 regulated candidate genes tested, we found that TRIB1 levels were also correlated with those for COX-2 (R ¼ 0.63, P , 0.001, N ¼ 284). As the majority of neonates enrolled in the GUSTO cohort are of Chinese ethnicity, we solely associated clinical anthropometric measurements from this group with candidate gene expression levels in cords. We also wanted to eliminate confounding factors based on gender and therefore used data from females only. By eliminating gender and ethnicity bias on correlations with BW data, we used 91 female Chinese subjects for the anthropometric analyses, as shown in Fig. 7B . Using this focused data set comprising 91 subjects, the correlations between the expression levels for COX-2 and EGR-1, as well as COX-2 and TRIB1 were similar to the heterogeneous larger data set (Fig. 7B, upper panel) . In addition, we also observed an association of EGR-1 expression levels with both BW and fetal abdominal circumference (AC) as measured by ultrasound parameters (Fig. 7B , lower panel).
Discussion
The evidence in support of an important developmental component to metabolic disease risk is described in the DOHaD paradigm . There are multiple pathways to increased risk (Gluckman and Hanson, 2004 Hanson, , 2006 , but the one that has had the most attention is that associated with less than optimal fetal nutrition. Fetal growth retardation can be seen as an immediate adaptive response to limiting nutritional conditions where longer term consequences, induced most probably by epigenetic processes, are either a trade-off against that immediate adaptation or an anticipatory or predictive adaptive response (Bateson 2008; Gluckman et al., 2011) . Insulin hypersensitivity which is seen at birth in SGA could be an immediate adaptive response to promote adipogenesis either for thermoregulatory purposes or as a later metabolic buffer after weaning (Kuzawa, 1998) . Insulin resistance which develops in childhood (Hofman et al., 1997; Mericq et al., 2005) is seen as a phenotype better adapted to poor nutritional circumstance (Hales and Barker, 1992) . But the underpinning mechanisms are poorly understood and in humans, ethical and practical limitations limit the types of investigation possible. We employed Wharton's jelly-derived MSCs as a potentially suitable tissue to study insulin sensitivity and the associated molecular pathways. To our knowledge, it has not been shown before that MSCs maintain phenotypic differences reflecting intrauterine experience. Two key questions are what determines the neonatal insulin hypersensitivity and how the transition is made from an insulin sensitive to a relatively insensitive state in childhood. One possible factor may be post-natal catch-up growth (Berends et al., 2013) . Rapid post-natal weight gain has been linked with insulin resistance in pre-pubertal children born with SGA (Faienza et al., 2013) .
Our gene expression microarray data obtained after comparison between the UC-MSC groups revealed that one of the most significant differentially expressed genes is the transcription factor EGR-1. The down-regulation of EGR-1 in the absence of insulin in UC-MSCs derived from SGA babies can explain their relative high proliferative rates as EGR-1 has been shown to function as tumour suppressor gene . It is also interesting to note that EGR-1 has been indirectly implicated in mammalian growth restriction (Baserga et al., 2010) . Furthermore, EGR-1 has been associated with insulin resistance and to be over-expressed in adipose tissue in adult subjects with type 2 diabetes Yu et al., 2011) .
How can EGR-1 potentially exert its function in stem cells from growth restricted babies? One explanation may be the concomitant overexpression of COX-2 in response to insulin, which we found only in the SGA group. COX-2 has multiple implications for the development of metabolic diseases. It catalyses the first two steps in the biosynthesis of prostaglandins (PGs), and its induction is mainly associated with inflammation and cytokine expression (Simmons et al., 2004) . COX-2 has important functions in metabolism promoting adipogenesis and potentially obesity (Fain et al., 2001) . Selective inhibitors of COX-2 have also been shown to ameliorate insulin sensitivity in normal subjects (González-Ortiz et al., 2001) . Furthermore, in rodent studies, COX-2 activation mediates inflammation in fat tissue leading to insulin resistance (Hsieh et al., 2009) .
More recent studies showed that the activity of COX-2 enhances the expression of UCP1 (Uncoupling protein1) in white adipose tissue, but not in brown adipose tissue (BAT) (Madsen et al., 2010) . BAT is abundant in small children and it is conceivable that the COX-2 over-expression in MSCs from growth-restricted babies echoes an important mechanism for producing body heat. For preterm and SGA babies, it is of primary importance to maintain body heat. In future, we will test this hypothesis in brown adipocytes differentiated from cord-derived MSCs. EGR-1 may be a key regulator in the biology of developmental programming and the transition towards insulin resistance and metabolic disease.
SOD2 and TRIB1 are genes in the network downstream of EGR-1 and were identified in our gene expression microarray experiments. Oxidative stress may be a contributing factor in the aetiology of metabolic disease of growth restricted babies (reviewed in Simmons 2012) . Indeed SOD2 mediates a metabolic switch during the progression from non-proliferating to proliferating human cells (Sarsour et al., 2012) . This could explain why EGR-1 and COX-2 mediated SOD2 up-regulation in our MSC model could have a negative impact on cell proliferation. We do not understand at present, why EGR-1 and COX-2 stimulate glucose uptake, but this effect may be mediated by the EGR-1-dependent increase in glucose transporters such as GLUT1 and GLUT4 (Fig. 6D ). This is a finding contradictory to previously published results for EGR-1 function in the development of insulin resistance Yu et al., 2011) . It is tempting to speculate that alternative pathways for glucose utilization are favoured in human MSCs and we are currently investigating this possibility. It may also be that increased oxidative stress contributes to the enhanced glucose uptake, as has been shown in skeletal muscle (Higaki et al., 2008) .
TRIB1 belongs to the Tribbles gene family, which comprises related serine/threonine kinase-like proteins (Yokoyama and Nakamura, 2011) . TRIB1 has been shown to be a negative regulator of smooth vascular muscle cell proliferation (Sung et al., 2007) , providing an additional possible mechanism by which EGR-1 inhibits cell proliferation via a downstream gene.
In summary, employing Wharton's jelly MSCs may prove a useful experimental approach to explore the biology of developmental programming. In particular, umbilical cord-derived MSC isolates may help to explain the transition from an early insulin-sensitive to an insulin-resistant phenotype in the course of developmental programming of insulin resistance in SGA individuals.
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Supplementary data are available at http://humrep.oxfordjournals.org/.
